Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty

NCT00657150 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

NCT00967447 ·Status: TERMINATED

RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

NCT00168805 ·Status: COMPLETED ·Phase: PHASE3

Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

NCT00152971 ·Status: COMPLETED ·Phase: PHASE3

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

NCT01523418 ·Status: WITHDRAWN

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

NCT01721837 ·Status: COMPLETED

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

NCT01431456 ·Status: COMPLETED ·Phase: PHASE3

Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty

NCT02379663 ·Status: COMPLETED ·Phase: PHASE4

Dose Ranging Study in Elective Total Hip Replacement Surgery

NCT00338897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

NCT01203098 ·Status: COMPLETED ·Phase: PHASE2

A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

NCT00398216 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

NCT00306254 ·Status: COMPLETED ·Phase: PHASE2

A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.

NCT00246025 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

NCT01181102 ·Status: COMPLETED ·Phase: PHASE3

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

NCT00398905 ·Status: COMPLETED ·Phase: PHASE2

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

NCT00375609 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

NCT00107900 ·Status: COMPLETED ·Phase: PHASE2

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

NCT00555438 ·Status: COMPLETED ·Phase: PHASE4

ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty

NCT06611319 ·Status: RECRUITING ·Phase: PHASE3

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Using Propensity Score Matching

NCT03483181 ·Status: UNKNOWN

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822 ·Status: COMPLETED ·Phase: PHASE2

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

NCT00353678 ·Status: COMPLETED ·Phase: PHASE2

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

NCT00371683 ·Status: COMPLETED ·Phase: PHASE3

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

NCT00831714 ·Status: COMPLETED